Cheung Chloe, Berger Sara M, Ross Meredith, Kramer Tamar, Li Yuhuan, Andrews Carli, Dergham Katia R, Spitz Elana, Florido Michelle E, Ahimaz Priyanka
Genetic Counseling Graduate Program, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Clinical Trials Office, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J Genet Couns. 2024 Dec;33(6):1312-1322. doi: 10.1002/jgc4.1860. Epub 2024 Jan 12.
Increased utilization of genomic sequencing in pediatric medicine has increased the detection of variants of uncertain significance (VUS). Periodic VUS reinterpretation can clarify clinical significance and increase diagnostic yield, highlighting the importance of systematic VUS tracking and reinterpretation. There are currently no standardized guidelines or established best practices for VUS management, and our understanding of how genetic counselors (GCs) track and manage VUS results for pediatric patients is limited. In this exploratory study, GCs in pediatric clinics in North America were surveyed about their VUS management practices. A total of 124 responses were included in the analysis. The majority (n = 115, 92.7%) of GCs reported that VUS management workflows were at the discretion of each individual provider in their workplace. Approximately half (n = 65, 52%) kept track of patient VUS results over time, and GCs with lower patient volumes were more likely to do so (p = 0.04). While 95% (n = 114) of GCs had requested VUS reinterpretation at least once, only 5% (n = 6) requested it routinely. Most (n = 80, 86%) GCs notified patients when a VUS was reclassified, although methods of recontact differed when the reclassification was an upgrade versus a downgrade. GCs who asked patients to stay in touch through periodic recontact or follow-up appointments were more likely to request VUS reinterpretation (p = 0.01). The most frequently reported barriers to requesting reinterpretation regularly were patients being lost to follow-up (n = 39, 33.1%), insufficient bandwidth (n = 27, 22.9%), and lack of standardized guidelines (n = 25, 21.2%). GCs had consistent overall practices around VUS management around investigation, disclosure, reinterpretation, and recontact, but specific methods used differed and were at the discretion of each provider. These results showcase the current landscape of VUS management workflows in pediatrics and the challenges associated with adopting more uniform practices. The study findings can help inform future strategies to develop standardized guidelines surrounding VUS management.
儿科医学中基因组测序应用的增加提高了意义未明变异(VUS)的检测率。定期对VUS进行重新解读可以阐明其临床意义并提高诊断率,这凸显了系统跟踪和重新解读VUS的重要性。目前对于VUS管理尚无标准化指南或既定的最佳实践,而且我们对遗传咨询师(GC)如何跟踪和管理儿科患者的VUS结果的了解有限。在这项探索性研究中,对北美儿科诊所的遗传咨询师进行了关于他们VUS管理实践的调查。分析共纳入了124份回复。大多数(n = 115,92.7%)遗传咨询师报告称,VUS管理工作流程由其工作场所的每个个体提供者自行决定。约一半(n = 65,52%)的遗传咨询师会长期跟踪患者的VUS结果,患者量较少的遗传咨询师更有可能这样做(p = 0.04)。虽然95%(n = 114)的遗传咨询师至少曾要求对VUS进行一次重新解读,但只有5%(n = 6)会定期要求重新解读。大多数(n = 80,86%)遗传咨询师在VUS重新分类时会通知患者,不过当重新分类是升级还是降级时,再次联系的方式有所不同。要求患者通过定期再次联系或随访预约保持联系的遗传咨询师更有可能要求对VUS进行重新解读(p = 0.01)。定期要求重新解读最常报告的障碍是患者失访(n = 39,33.1%)、带宽不足(n = 27,22.9%)以及缺乏标准化指南(n = 25,21.2%)。遗传咨询师在围绕VUS管理的调查、披露、重新解读和再次联系方面有一致的总体实践,但具体使用的方法有所不同,且由每个提供者自行决定。这些结果展示了儿科VUS管理工作流程的当前状况以及采用更统一做法所面临的挑战。研究结果有助于为制定围绕VUS管理的标准化指南的未来策略提供信息。